Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma

door Regan, Paul L., Jacobs, Joshua, Wang, Gerald, Torres, Jaime, Edo, Robby, Friedmann, Jennifer, Tang, Xao X.
Gepubliceerd in 2011

Immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM)

door Lapointe, Réjean, Jamal, Rahima, van Kempen, Leon, Thebault, Pamela, Belanger, Karl, Friedmann, Jennifer, Ayoub, Jean-Pierre, Cocolakis, Eftihia, Kazemi, Shirin, Dionne, Jeanne, Lambert, Caroline, Le, Huy, Grange, Cecile, Cailhier, Jean-Francois, Spatz, Alan, Miller, Wilson
Gepubliceerd in J Immunother Cancer (2015)

Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma

door Jamal, Rahima, Lapointe, Réjean, Cocolakis, Eftihia, Thébault, Paméla, Kazemi, Shirin, Friedmann, Jennifer E., Dionne, Jeanne, Cailhier, Jean-François, Bélanger, Karl, Ayoub, Jean-Pierre, Le, Huy, Lambert, Caroline, El-Hajjar, Jida, van Kempen, Léon C., Spatz, Alan, Miller, Wilson H.
Gepubliceerd in J Immunother Cancer (2017)